FDA’s Generic Drug Office Goes On Diet Before Swallowing User Fees
Executive Summary
Congress sets $52.9 million floor for Office of Generic Drugs in FY 2012, less than in 2011, as part of $3.8 billion FDA funding package. Overall, FDA gets a $50 million boost, but sequestration looms. Appropriations conferees enter the user fee debate, asking how fast FDA approves drug applications.
You may also be interested in...
FDA Considers Cuts And Initiatives For Fiscal 2014 – Hamburg
Commissioner Hamburg tells FDA’s Science Board that in the early stages, both cuts and expansions are on the table as the budget process begins in preparation for the fiscal year starting October 2013.
FDA Considers Cuts And Initiatives For Fiscal 2014 – Hamburg
Commissioner Hamburg tells FDA’s Science Board that in the early stages, both cuts and expansions are on the table as the budget process begins in preparation for the fiscal year starting October 2013.
FDA Facing Possible Cuts – Or New Initiatives – In FY 2014 Budget, Hamburg Says
Commissioner tells agency science board that both are on the table as the budget process begins in preparation for the fiscal year that begins in October 2013.